AURA (Aura Biosciences) FCF Margin %: 0.00% (As of Mar. 2026)


AURA Aura Biosciences Inc AURA
35 GF Score
Price $7.04
! 3 Warning Signs
View Full Analysis

What is Aura Biosciences FCF Margin %?

Aura Biosciences AURA +0.36% 35 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates AURA with a GF Score™ of 35/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Aura Biosciences ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Aura Biosciences's Free Cash Flow for the three months ended in Mar. 2026 was $-30.00 Mil. Aura Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Aura Biosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Aura Biosciences's current FCF Yield % is -12.60%.

The historical rank and industry rank for Aura Biosciences's FCF Margin % or its related term are showing as below:


AURA's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Aura Biosciences FCF Margin % Related Terms

Aura Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Aura Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aura Biosciences FCF Margin % Chart

Aura Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Aura Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AURA vs PHAT, SMNR, CTMX: FCF Margin % Comparison

For the Biotechnology subindustry, Aura Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aura Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aura Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Aura Biosciences's FCF Margin % falls into.


AURA
35GF Score
Aura Biosciences Inc AURA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aura Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Aura Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-85.189/0
= %

Aura Biosciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-29.995/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Aura Biosciences (AURA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aura Biosciences and its competitors. According to the industry distribution chart, Aura Biosciences ranks #999999 out of 960 companies in the Biotechnology industry.
Is Aura Biosciences' FCF Margin % too high?
Aura Biosciences' current FCF Margin % is 0.00%. Based on the distribution chart, Aura Biosciences ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aura Biosciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Aura Biosciences' FCF Margin % compare to PHAT and SMNR?
According to the Biotechnology industry distribution chart, Aura Biosciences ranks #999999 out of 960 companies for FCF Margin %. This places Aura Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aura Biosciences and its competitors. Aura Biosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aura Biosciences stock overvalued right now?
Aura Biosciences (AURA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Aura Biosciences' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Aura Biosciences (AURA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aura Biosciences Business Description

Address 80 Guest Street, Boston, MA, USA, 02135
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
35GF Score

Get the complete analysis for AURA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.04
Price